Erschienen in:
01.12.2005 | Review
Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options
verfasst von:
Nathalie Costedoat-Chalumeau, Zahir Amoura, Elisabeth Villain, Laurence Cohen, Jean-Charles Piette
Erschienen in:
Arthritis Research & Therapy
|
Ausgabe 2/2005
Einloggen, um Zugang zu erhalten
Abstract
Apart from complete and incomplete congenital heart block (CHB), new cardiac manifestations related to anti-SSA/Ro antibodies have been reported in children born to mothers bearing these antibodies. These manifestations include transient fetal first-degree heart block, prolongation of corrected QT (QTc) interval, sinus bradycardia, late-onset cardiomyopathy, endocardial fibroelastosis and cardiac malformations. Anti-SSA/Ro antibodies are not considered pathogenic to the adult heart, but a prolongation of the QTc interval has recently been reported in adult patients and is still a matter of debate. Treatment of CHB is not well established and needs to be assessed carefully. The risks and benefits of prenatal fluorinated steroids are discussed.